Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

University of Michigan issued U.S. patent for gene transfer technology

July 19, 1996

CytoTherapeutics announces new biotech company

July 19, 1996

Search for new drug using genomic technology brings together 3 companies in collaboration

July 19, 1996

Myriad Genetics and Intermountain Health Care collaborate on CNS disorders

July 19, 1996

Stat4 gene research at Tularik and Harvard University

July 19, 1996

Neuropeptide Y Y5 receptor linked to obesity and eating disorders

July 19, 1996

Roche begins screening for obesity drug candidates

July 19, 1996

C-Maf T-cell switch factor: Important component of Boston Life Science's R&D

July 19, 1996

Genome Therapeutics and Merck & Co. sign licensing agreement

July 19, 1996

Roche licenses PCR technology to Immuno

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...